In fiscal year 2023, the global Drug Eruptions Treatment Market revenue is expected to be worth US$ 3.89 billion, up from US$ 3.66 billion in fiscal year 2022. The global market is expected to grow at a 6.2% CAGR from 2023 to 2033, reaching US$ 7.1 billion by the end of that year. A drug …
Category Archives: Healthcare Trends
Edward’s Syndrome Treatment Market Size 2023 to 2033 | By Pfizer, Bellus Health, Sanofi, Merck, Bayer AG
The Edward’s Syndrome Treatment Market demand is expected to grow at a 5% CAGR between 2023 and 2033, according to Future Market Insights. The global market for Edward’s Syndrome Treatment is expected to reach US$ 7.98 billion by 2033. The market’s growth can be attributed to technical advancements in diagnostic testing and the development of …
Fucosidosis Therapeutics Market is expected to reach US$ 17.91 Million by 2033, at a CAGR of 6%
With a CAGR of 6% from 2023 to 2033, the global Fucosidosis Therapeutics Market sales is anticipated to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033. The Fucosidosis Therapeutics market increased at a 4% CAGR between 2018 and 2022. According to studies, fucosidosis is a rare autosomal recessive lysosomal storage …
Filariasis Treatment Market Share 2023 to 2033 | By AbbVie, Elsai, Cipla, Pfizer, Novartis AG
According to Future Market Insights, the global Filariasis Treatment Market demand will develop at a 10.1% compound annual growth rate (CAGR) between 2023 and 2033, reaching a value of US$ 28.68 billion by 2033. The rising prevalence of filariasis, enhanced diagnostic capabilities, and increased awareness of the disease are projected to fuel market expansion. Furthermore, …
Swab and Viral Transport Medium Market is projected to register a 5.8% CAGR and top a valuation of US$ 15.60 billion by 2033
The global Swab and Viral Transport Medium Market may exceed US$ 8.86 billion in 2023, according to a recent market analysis by FMI. According to FMI’s prediction, the market might expand at a 5.8% CAGR and reach a value of $15.60 billion by 2033. Due to the COVID-19 outbreak, swabs and viral delivery mediums are …
Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market is expected to reach US$ 5.5 Billion by 2030
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market was estimated at US$ 3.8 billion in 2021 and is predicted to reach US$ 5.5 billion by 2030, according to a new market analysis conducted by Future Market Insights (FMI). Among the serious illnesses brought on by Staphylococcus aureus germs include sepsis, toxic shock syndrome, bacteremia, osteomyelitis, …
Respiratory Pathogen Testing Kits Market is expected to surpass US$ 7,136.8 million a CAGR of 5.7% through 2033
The global Respiratory Pathogen Testing Kits Market is anticipated to grow at a CAGR of 5.7% from 2023 to 2033, according to the most recent market research study by FMI. The market is anticipated to grow to a value of US$ 4083 million in 2023. The worth is predicted to reach US$ 7136.8 million by …
Japan’s Pneumococcal Testing Market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 9.8% CAGR from 2022 to 2030
The Global Pneumococcal Testing Market is expected to reach US$ 3.6 billion by 2030, according to a recent industry study by Future Market Insights (FMI). The market is currently estimated to be worth US$ 1.6 billion in 2022. Due to its present diagnostic landscape, which includes unmet needs and rising technology, pneumococcal testing is becoming …
Non-opioid Pain Patches Market is Expanding at a healthy 4.1% CAGR, the size is projected to total US$ 4.4 Billion by 2029
Sales of Non-opioid Pain Patches Market are projected to total US$ 3.3 billion in 2022. The market is anticipated to reach US$ 4.4 billion by 2029, expanding at a strong 4.1% CAGR. Due to the potential for addiction and safety concerns associated with alternative opioid pain relievers, non-opioid pain patches have recently attracted the interest …
Preterm Birth Prevention and Management Market is forecast to register a CAGR of 10.1% between 2022 and 2029
In 2022, the Preterm Birth Prevention and Management Market is anticipated to be valued roughly US$1.41 billion. Preterm birth prevention and management treatments are becoming more widely used in both developed and developing nations, and it is predicted that between 2022 and 2029, the global market will expand at a CAGR of 10.1%, reaching a …